Application of single targeted therapies in cancer has caused resistance in tumors, especially the
heterogeneous tumors such as lung cancer. Here we propose a different strategy in approaching
heterogeneous tumors, looking at a sequential but systemic and pan-genomic targeted therapy through
epigenetic modifications. We aim to trigger new hypotheses and generate provoking scientific methods
to address current challenges in oncology care.
